BMS settles Plavix deal probe
31 March 2009
Nancy Faigen
Bristol-Myers Squibb has agreed to pay a civil fine of $2.1 million to end a US Federal Trade Commission probe into the company's failed 2006 attempt to negotiate a favourable drug patent settlement for Plavix (clopidogrel) with
Apotex.
On March 26th, the FTC filed a complaint in the US District...
Please Login to read the full article.
31 March 2009
Nancy Faigen
On March 26th, the FTC filed a complaint in the US District...
Please Login to read the full article.
RELATED CONTENT
NEWS
- HHS drops Solomon exclusion, and critics focus on Forest's revenue forecasts
- Supreme Court upholds 'clear and convincing' patent standard, rules against Microsoft
- US Capitol Capsule: Federal shutdown averted, but spending reductions could spell trouble for expensive drugs
- Regeneron can open eyes now as Genentech Eylea litigation outcome clears overhang
COMMENT
Other Informa Comment
EVENTS
09 February 2012
London
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
